Sarepta Therapeutic Now Covered by Leerink Swann (SRPT)
Leerink Swann initiated coverage on shares of Sarepta Therapeutic (NASDAQ: SRPT) in a research report sent to investors on Tuesday morning. The firm issued an outperform rating and a $45.00 price target on the stock.
Shares of Sarepta Therapeutic opened at 31.31 on Tuesday. Sarepta Therapeutic has a 52 week low of $3.30 and a 52 week high of $45.00. The stock’s 50-day moving average is currently $27.49. The company’s market cap is $796.9 million.
A number of other analysts have also recently weighed in on SRPT. Analysts at Cowen initiated coverage on shares of Sarepta Therapeutic in a research note to investors on Friday, January 25th. They set an outperform rating on the stock. Separately, analysts at Piper Jaffray cut their price target on shares of Sarepta Therapeutic to $35.00 in a research note to investors on Wednesday, January 2nd. They now have a positive rating on the stock. Finally, analysts at Piper Jaffray reiterated a positive rating on shares of Sarepta Therapeutic in a research note to investors on Friday, December 7th.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.